Vevye: A New Cyclosporine Solution for Dry Eye Disease
XTalks
JUNE 14, 2023
Furthermore, the bioavailability of the active pharmaceutical ingredient (API) into the cornea is up to four times stronger with EyeSol technology. Attendees will understand best practices for novel drug delivery design and development. The key active ingredient, cyclosporine, functions as a selective immunomodulatory drug.
Let's personalize your content